William Jl Rieflin - 31 Mar 2023 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Role
Director
Signature
/s/ Rodney Young, Attorney-in-Fact for William Rieflin
Issuer symbol
RAPT
Transactions as of
31 Mar 2023
Transactions value $
$87,498
Form type
4
Date filed
10 Apr 2023, 20:10
Previous filing
10 Jun 2022
Next filing
12 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPT Stock Option (right to buy) Award $87.5K +6.03K $14.52 6.03K 31 Mar 2023 Common Stock 6.03K $18.35 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2023 with the first installment vesting on March 31, 2023, provided that the reporting person is in service as a director on each such vesting date.
F2 This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $87,500.